Butterfly Network signs multi-year ultrasound-on-chip licensing deal with Merge Labs for BCI development
BFLY•Multi-year licensing deal with Merge Labs
Butterfly Network signed a multi-year licensing deal with Merge Labs to support ultrasound-based brain-computer interface development.
Merge gains access to Butterfly’s Poseidon Ultrasound-on-Chip technology through Butterfly Embedded.
Terms include upfront payments, milestone-based license fees, hardware purchase commitments, technology access fees, and ongoing royalties on future commercial sales.
Butterfly becomes Merge’s exclusive CMOS-MEMS chip-based ultrasound partner, while retaining rights to license its technology to others.
Merge launched in January 2026 with $252 million in seed funding from investors including OpenAI, Bain Capital, and Interface Fund.
